Carbzah Solution
NDC Package 71085-080-07

11-digit billing NDC: 71085008007 · Billing unit: ML · 473 ML per package
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Carbzah (carbinoxamine maleate) solution is carbinoxamine maleate is effective for the symptomatic treatment of:Seasonal and perennial allergic rhinitis.Vasomotor rhinitis.Allergic conjunctivitis due to inhalant allergens and foods.Mild, uncomplicated allergic skin manifestations of urticaria and angioedema.Dermatographism.As therapy for anaphylactic reactions adjunctiveto epinephrine and other standard measures after the acute manifestations have been controlled. This formulation utilizes a solution delivery system. Marketed by Ipg Pharmaceuticals, Inc., this product is identified by NDC 71085-080 and is authorized under FDA application ANDA040458.

Identification & Billing

NDC Package Code
71085-080-07
Package Description
473 mL in 1 BOTTLE, PLASTIC
Product Code
71085-080
11-Digit Billing Format
71085008007
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
Units Per Package
473 ML
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Carbzah
Non-Proprietary Name
Carbinoxamine Maleate
Substance Name
Carbinoxamine Maleate
Dosage Form
Solution - A clear, homogeneous liquid1 dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
CARBINOXAMINE MALEATE 4 mg/5mL
Pharmacologic Class
Usage Information
Carbinoxamine maleate is effective for the symptomatic treatment of:Seasonal and perennial allergic rhinitis.Vasomotor rhinitis.Allergic conjunctivitis due to inhalant allergens and foods.Mild, uncomplicated allergic skin manifestations of urticaria and angioedema.Dermatographism.As therapy for anaphylactic reactions adjunctiveto epinephrine and other standard measures after the acute manifestations have been controlled. Amelioration of the severity of allergic reactions to blood or plasma.

Regulatory & Marketing

Labeler Name
Ipg Pharmaceuticals, Inc.
Product Type
Human Prescription Drug
FDA Application #
ANDA040458
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
06-01-2025
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 71085-080-07 identifies a specific commercial package of 473 ml in 1 bottle, plastic of Carbzah, a human prescription drug labeled by Ipg Pharmaceuticals, Inc.. This product is billed per "ML" milliliter and contains an estimated amount of 473 billable units per package. This solution is formulated for oral use and contains carbinoxamine maleate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Ipg Pharmaceuticals, Inc. on June 01, 2025. The current certification is valid through December 31, 2027.

How is this Ipg Pharmaceuticals, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 71085008007. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 473 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
71085-080-07
11-Digit CMS (5-4-2)
71085-0080-07

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.